Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jinny Tavee, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00981643
First received: September 21, 2009
Last updated: September 7, 2011
Last verified: September 2011

September 21, 2009
September 7, 2011
February 2009
November 2009   (final data collection date for primary outcome measure)
To determine if meditation has a beneficial effect on pain, fatigue and physical functioning in patients with multiple sclerosis and peripheral neuropathy [ Time Frame: 2 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00981643 on ClinicalTrials.gov Archive Site
To determine, in the neuropathy arms, if there is an improvement seen on the neurological evaluation with regards to weakness and sensory changes with meditation [ Time Frame: 2 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy
The Effects of Meditation on Pain, Fatigue and Physical Functioning in Patients With Multiple Sclerosis and Peripheral Neuropathy

This study will evaluate the effects of mindfulness and concentration meditation on pain, fatigue, and physical functioning in patients with either multiple sclerosis or peripheral neuropathy.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
  • Multiple Sclerosis
  • Peripheral Neuropathy
Behavioral: Meditation instruction and practice
Meditation techniques introduced and practiced, in a group setting, once weekly for 8 weeks
  • Experimental: Multiple Sclerosis, Meditation group
    Intervention: Behavioral: Meditation instruction and practice
  • No Intervention: Multiple Sclerosis, Control group
  • Experimental: Peripheral Neuropathy, Meditation group
    Intervention: Behavioral: Meditation instruction and practice
  • No Intervention: Peripheral Neuropathy, Control group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
December 2010
November 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of multiple sclerosis OR peripheral neuropathy

Exclusion Criteria:

  • Unable to walk without the assistance of others
  • Unable to toilet independently
  • Currently abusing drugs or alcohol
  • Have performed meditation within the last 6 months
  • Cognitive impairment or an underlying illness which would prevent the comprehension of instructions
  • History of symptomatic/unstable heart or lung disease
  • Uncontrolled high blood pressure
  • Kidney or renal failure
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00981643
CCF 08-950
No
Jinny Tavee, The Cleveland Clinic
The Cleveland Clinic
Not Provided
Principal Investigator: Jinny Tavee, MD The Cleveland Clinic
The Cleveland Clinic
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP